ICU Medical Inc (ICUI)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-29,655	-28,044	-48,490	-46,030	-74,286	-38,825	5,464	41,336	103,135	109,352	103,257	93,767	86,870	81,369	82,946	86,871	101,035	73,039	46,695	54,916
Total stockholders’ equity	US$ in thousands	2,123,410	2,098,360	2,114,820	2,100,400	2,089,930	2,012,800	2,085,870	2,178,900	1,616,030	1,589,970	1,557,260	1,520,770	1,502,260	1,452,220	1,411,800	1,375,890	1,377,240	1,340,340	1,317,860	1,282,690
ROE		-1.40%	-1.34%	-2.29%	-2.19%	-3.55%	-1.93%	0.26%	1.90%	6.38%	6.88%	6.63%	6.17%	5.78%	5.60%	5.88%	6.31%	7.34%	5.45%	3.54%	4.28%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-29,655K ÷ $2,123,410K
= -1.40%

ICU Medical, Inc.'s Return on Equity (ROE) has shown a negative trend in recent quarters, indicating that the company is generating less profit with each dollar of shareholders' equity. The ROE figures have ranged from -3.55% to -1.34% in the last year. The decreasing trend in ROE suggests that the company may be facing challenges in efficiently utilizing the equity capital to generate profits for shareholders. It is important for investors to closely monitor the company's financial performance and management strategies to assess potential risks and evaluate the long-term sustainability of returns on their investments.